Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments.
Mahmoud S. Alghamri,Brandon L. McClellan,Margaret S. Hartlage,Santiago Haase,Syed M Faisal,Rohit Thalla,Ali Dabaja,Kaushik Banerjee,Stephen Carney,Anzar A. Mujeeb,Michael R. Olin,James J. Moon,Anna Schwendeman,Pedro R. Lowenstein,Maria G. Castro +14 more
Reads0
Chats0
TLDR
Glioblastomas are one of the most lethal types of cancers accounting for ~80% of all central nervous system (CNS) primary malignancies [1, as discussed by the authors.Abstract:
Gliomas are one of the most lethal types of cancers accounting for ~80% of all central nervous system (CNS) primary malignancies [1; 2]. Amongst gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15 months. Recent molecular characterization studies uncovered the genetic signatures and methylation status of gliomas and correlate these with clinical prognosis [2]. The most relevant molecular characteristics for the new glioma classification are IDH mutation, chromosome 1p/19q deletion, histone mutations, and other genetic parameters such as ATRX loss, TP53, and TERT mutations, as well as DNA methylation levels. Similar to other solid tumors, glioma progression is impacted by the complex interactions between the tumor cells and immune cells within the tumor microenvironment. The immune system’s response to cancer can impact the glioma’s survival, proliferation, and invasiveness. Salient characteristics of gliomas include enhanced vascularization, stimulation of a hypoxic tumor microenvironment, increased oxidative stress, and an immune suppressive milieu. These processes promote the neuro-inflammatory tumor microenvironment which can lead to the loss of blood-brain barrier (BBB) integrity. The consequences of a compromised BBB are deleteriously exposing the brain to potentially harmful concentrations of substances from the peripheral circulation, adversely affecting neuronal signaling, and abnormal immune cell infiltration; all of which can lead to disruption of brain homeostasis. In this review, we first describe the unique features of inflammation in CNS tumors. We then discuss the mechanisms of tumor-initiating neuro-inflammatory microenvironment and its impact on tumor invasion and progression. Finally, we also discuss potential pharmacological interventions that can be used to target neuro-inflammation in gliomas.read more
Citations
More filters
Journal ArticleDOI
RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS
Reshma Raghava Kurup,Eimile Oakes,Aidan C. Manning,Priyanka Mukherjee,Pranathi Vadlamani,Heather A. Hundley +5 more
TL;DR: In this article , a global view of ADAR3-bound RNAs in glioblastoma cells and identifies both a role for ADAR-3 in repressing ADAR1-mediated editing and an RNA-binding dependent function of adar3 in regulating MAVS expression.
Journal ArticleDOI
Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches.
TL;DR: In this article, a review of recent advances in imaging methods that have helped to improve the specificity of primary tumor diagnosis versus evaluation of inflamed and necrotic brain lesions is presented.
Journal ArticleDOI
Dopamine, Immunity, and Disease
Breana Channer,Stephanie M. Matt,E. A. Nickoloff-Bybel,Vassiliki Pappa,Yash Agarwal,Jason R Wickman,Peter J. Gaskill +6 more
TL;DR: In this article , a review comprehensively assesses the current knowledge of dopaminergic immunology at the cellular, tissue, and disease level and prompts the development of therapeutics and strategies targeted toward ameliorating disease through dopamine regulation of immunity.
Journal ArticleDOI
Neuroinflammatory mediators in acquired epilepsy: an update
Yu Chen,Marwa M. Nagib,Nelufar Yasmen,Madison N. Sluter,Taylor L Littlejohn,Ying Yu,Jianxiong Jiang +6 more
Journal ArticleDOI
Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus
TL;DR: The risk of malignant brain tumors associated with metformin use has rarely been investigated in humans as discussed by the authors, and the authors in this retrospective cohort study investigated such an association in humans.
References
More filters
Journal ArticleDOI
Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas
Lindsay Scheetz,Padma Kadiyala,Xiaoqi Sun,Sejin Son,Alireza Hassani Najafabadi,Marisa E. Aikins,Pedro R. Lowenstein,Anna Schwendeman,Maria G. Castro,James J. Moon +9 more
TL;DR: It is demonstrated that vaccination with neoantigen peptide-sHDL/CpG cocktail in combination with anti–PD-L1 immune checkpoint blocker elicits robust neo-antigen-specific T-cell responses against GL261 cells and eliminated established orthotopic glioma in 33% of mice.
Journal ArticleDOI
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors
Daniela Damiani,Mario Tiribelli,Donatella Raspadori,Santina Sirianni,Alessia Meneghel,Margherita Cavalllin,Angela Michelutti,Eleonora Toffoletti,Antonella Geromin,Erica Simeone,Monica Bocchia,Renato Fanin +11 more
TL;DR: CD200 is emerging as both a prognostic factor and a potential target of novel therapeutic approaches for AML, aiming to reverse the “do not eat me” signal of CD200 or to manipulate the suppressive immune microenvironment induced by CD200 binding to its receptor.
Journal ArticleDOI
Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice
TL;DR: Evidence is reported for a role for CD200 expression (by the host and/or tumor cells) in increased seeding of tumor cells to DLN in immunocompromised mice or NOD-SCID.
Journal ArticleDOI
Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry.
Daniel E. Carvajal-Hausdorf,Daniel E. Carvajal-Hausdorf,Jonathan Patsenker,Jonathan Patsenker,Kelly P. Stanton,Franz Villarroel-Espindola,Amanda Esch,Ruth R. Montgomery,Amanda Psyrri,Konstantine T. Kalogeras,Vassiliki Kotoula,George Foutzilas,Kurt A. Schalper,Yuval Kluger,David L. Rimm +14 more
TL;DR: The proximity of CD8 cells as a function of the expression of the ECD of HER2 provides further evidence for the role of the immune system in the mechanism of action of trastuzumab.
Journal ArticleDOI
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
Lara Gibellini,Sara De Biasi,Camillo Porta,Domenico Lo Tartaro,Roberta Depenni,Giovanni Pellacani,Roberto Sabbatini,Andrea Cossarizza +7 more
TL;DR: Cutting-edge single-cell approaches are helping to point out the heterogeneity of immune cells in the tumor microenvironment and in blood, besides the molecular and cellular cancer-immune system interactions.